Lanthanum Orifarm (Lanthanum)

Lanthanum carbonate releases lanthanum ions in the acidic stomach environment. These ions bind dietary phosphate to form insoluble lanthanum phosphate complexes that are not absorbed. The complexes are excreted in the feces, reducing the amount of phosphate entering the bloodstream and thereby lowering serum phosphate concentrations.

The dose of Lanthanum Orifarm is individualized by the prescribing clinician based on the patient’s serum phosphate levels, dietary intake, and renal function. Typical regimens involve multiple tablets taken with meals, but the exact amount and frequency must be determined by a qualified healthcare professional.

Safety data for lanthanum in pregnancy and lactation are limited. It should only be used when the potential benefit to the mother outweighs any possible risk to the fetus or infant, and the decision must be made by the treating physician in consultation with the patient.

To order Lanthanum Orifarm, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and necessary import documentation.

Lanthanum Orifarm offers a high phosphate‑binding capacity with a relatively low tablet burden compared with calcium‑based binders, which can increase calcium load. Compared with sevelamer, lanthanum does not contain aluminum or magnesium and may have a different side‑effect profile, but both require monitoring of serum phosphate and potential gastrointestinal effects.

Store Lanthanum Orifarm tablets at ambient temperature, preferably below 25 °C. Keep the product in its original container, protect it from moisture and direct sunlight, and ensure the packaging remains sealed until use to maintain stability.

Lanthanum Orifarm is taken orally as a tablet with meals. The tablets should be swallowed whole with a full glass of water and should not be crushed or chewed. To avoid reduced efficacy, separate its administration from antacids, iron, or calcium supplements by at least two hours.

The most serious risks include severe constipation that can progress to intestinal obstruction, allergic reactions ranging from rash to anaphylaxis, and rare elevations in liver enzymes. Patients should be instructed to report persistent abdominal pain, vomiting, or signs of an allergic response promptly.

Lanthanum Orifarm should be avoided in individuals with known hypersensitivity to lanthanum or any component of the formulation, in patients with severe gastrointestinal obstruction, and in those who cannot safely separate its intake from interacting medications such as aluminum‑ or magnesium‑containing antacids.